Medical Care
Global Thalassemia Market Research Report 2025
- Sep 09, 25
- ID: 494434
- Pages: 99
- Figures: 93
- Views: 20
This report aims to provide a comprehensive presentation of the global market for Thalassemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thalassemia.
The Thalassemia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Thalassemia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thalassemia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Merck (Acceleron Pharma)
Celgene Corporation
Kiadis Pharma
Incyte Corporation
Segment by Type
Iron Chelation Therapy
Transfusion Therapy
Bone Marrow Transplant
Others
Segment by Application
Aldult
Newborns and Children
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thalassemia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Thalassemia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Thalassemia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thalassemia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Merck (Acceleron Pharma)
Celgene Corporation
Kiadis Pharma
Incyte Corporation
Segment by Type
Iron Chelation Therapy
Transfusion Therapy
Bone Marrow Transplant
Others
Segment by Application
Aldult
Newborns and Children
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thalassemia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thalassemia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Iron Chelation Therapy
1.2.3 Transfusion Therapy
1.2.4 Bone Marrow Transplant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Thalassemia Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Aldult
1.3.3 Newborns and Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thalassemia Market Perspective (2020-2031)
2.2 Global Thalassemia Growth Trends by Region
2.2.1 Global Thalassemia Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Thalassemia Historic Market Size by Region (2020-2025)
2.2.3 Thalassemia Forecasted Market Size by Region (2026-2031)
2.3 Thalassemia Market Dynamics
2.3.1 Thalassemia Industry Trends
2.3.2 Thalassemia Market Drivers
2.3.3 Thalassemia Market Challenges
2.3.4 Thalassemia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thalassemia Players by Revenue
3.1.1 Global Top Thalassemia Players by Revenue (2020-2025)
3.1.2 Global Thalassemia Revenue Market Share by Players (2020-2025)
3.2 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Thalassemia Revenue
3.4 Global Thalassemia Market Concentration Ratio
3.4.1 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thalassemia Revenue in 2024
3.5 Global Key Players of Thalassemia Head office and Area Served
3.6 Global Key Players of Thalassemia, Product and Application
3.7 Global Key Players of Thalassemia, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Thalassemia Breakdown Data by Type
4.1 Global Thalassemia Historic Market Size by Type (2020-2025)
4.2 Global Thalassemia Forecasted Market Size by Type (2026-2031)
5 Thalassemia Breakdown Data by Application
5.1 Global Thalassemia Historic Market Size by Application (2020-2025)
5.2 Global Thalassemia Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Thalassemia Market Size (2020-2031)
6.2 North America Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Thalassemia Market Size by Country (2020-2025)
6.4 North America Thalassemia Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thalassemia Market Size (2020-2031)
7.2 Europe Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Thalassemia Market Size by Country (2020-2025)
7.4 Europe Thalassemia Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thalassemia Market Size (2020-2031)
8.2 Asia-Pacific Thalassemia Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Thalassemia Market Size by Region (2020-2025)
8.4 Asia-Pacific Thalassemia Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thalassemia Market Size (2020-2031)
9.2 Latin America Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Thalassemia Market Size by Country (2020-2025)
9.4 Latin America Thalassemia Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thalassemia Market Size (2020-2031)
10.2 Middle East & Africa Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Thalassemia Market Size by Country (2020-2025)
10.4 Middle East & Africa Thalassemia Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Details
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Thalassemia Introduction
11.1.4 Emmaus Medical Revenue in Thalassemia Business (2020-2025)
11.1.5 Emmaus Medical Recent Development
11.2 Addmedica
11.2.1 Addmedica Company Details
11.2.2 Addmedica Business Overview
11.2.3 Addmedica Thalassemia Introduction
11.2.4 Addmedica Revenue in Thalassemia Business (2020-2025)
11.2.5 Addmedica Recent Development
11.3 Gamida Cell
11.3.1 Gamida Cell Company Details
11.3.2 Gamida Cell Business Overview
11.3.3 Gamida Cell Thalassemia Introduction
11.3.4 Gamida Cell Revenue in Thalassemia Business (2020-2025)
11.3.5 Gamida Cell Recent Development
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Details
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Thalassemia Introduction
11.4.4 GlycoMimetics Revenue in Thalassemia Business (2020-2025)
11.4.5 GlycoMimetics Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Thalassemia Introduction
11.5.4 Pfizer Revenue in Thalassemia Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Thalassemia Introduction
11.6.4 Novartis Revenue in Thalassemia Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Details
11.7.2 Global Blood Therapeutics Business Overview
11.7.3 Global Blood Therapeutics Thalassemia Introduction
11.7.4 Global Blood Therapeutics Revenue in Thalassemia Business (2020-2025)
11.7.5 Global Blood Therapeutics Recent Development
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Details
11.8.2 Micelle BioPharma Business Overview
11.8.3 Micelle BioPharma Thalassemia Introduction
11.8.4 Micelle BioPharma Revenue in Thalassemia Business (2020-2025)
11.8.5 Micelle BioPharma Recent Development
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Details
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio Thalassemia Introduction
11.9.4 Bluebird Bio Revenue in Thalassemia Business (2020-2025)
11.9.5 Bluebird Bio Recent Development
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Details
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Thalassemia Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Thalassemia Business (2020-2025)
11.10.5 Prolong Pharmaceuticals Recent Development
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Details
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Thalassemia Introduction
11.11.4 Modus Therapeutics Revenue in Thalassemia Business (2020-2025)
11.11.5 Modus Therapeutics Recent Development
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Details
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Thalassemia Introduction
11.12.4 Sangamo Biosciences Revenue in Thalassemia Business (2020-2025)
11.12.5 Sangamo Biosciences Recent Development
11.13 Bioverativ
11.13.1 Bioverativ Company Details
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Thalassemia Introduction
11.13.4 Bioverativ Revenue in Thalassemia Business (2020-2025)
11.13.5 Bioverativ Recent Development
11.14 Imara
11.14.1 Imara Company Details
11.14.2 Imara Business Overview
11.14.3 Imara Thalassemia Introduction
11.14.4 Imara Revenue in Thalassemia Business (2020-2025)
11.14.5 Imara Recent Development
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Thalassemia Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Thalassemia Business (2020-2025)
11.15.5 Ironwood Pharmaceuticals Recent Development
11.16 Merck (Acceleron Pharma)
11.16.1 Merck (Acceleron Pharma) Company Details
11.16.2 Merck (Acceleron Pharma) Business Overview
11.16.3 Merck (Acceleron Pharma) Thalassemia Introduction
11.16.4 Merck (Acceleron Pharma) Revenue in Thalassemia Business (2020-2025)
11.16.5 Merck (Acceleron Pharma) Recent Development
11.17 Celgene Corporation
11.17.1 Celgene Corporation Company Details
11.17.2 Celgene Corporation Business Overview
11.17.3 Celgene Corporation Thalassemia Introduction
11.17.4 Celgene Corporation Revenue in Thalassemia Business (2020-2025)
11.17.5 Celgene Corporation Recent Development
11.18 Kiadis Pharma
11.18.1 Kiadis Pharma Company Details
11.18.2 Kiadis Pharma Business Overview
11.18.3 Kiadis Pharma Thalassemia Introduction
11.18.4 Kiadis Pharma Revenue in Thalassemia Business (2020-2025)
11.18.5 Kiadis Pharma Recent Development
11.19 Incyte Corporation
11.19.1 Incyte Corporation Company Details
11.19.2 Incyte Corporation Business Overview
11.19.3 Incyte Corporation Thalassemia Introduction
11.19.4 Incyte Corporation Revenue in Thalassemia Business (2020-2025)
11.19.5 Incyte Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thalassemia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Iron Chelation Therapy
1.2.3 Transfusion Therapy
1.2.4 Bone Marrow Transplant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Thalassemia Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Aldult
1.3.3 Newborns and Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thalassemia Market Perspective (2020-2031)
2.2 Global Thalassemia Growth Trends by Region
2.2.1 Global Thalassemia Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Thalassemia Historic Market Size by Region (2020-2025)
2.2.3 Thalassemia Forecasted Market Size by Region (2026-2031)
2.3 Thalassemia Market Dynamics
2.3.1 Thalassemia Industry Trends
2.3.2 Thalassemia Market Drivers
2.3.3 Thalassemia Market Challenges
2.3.4 Thalassemia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thalassemia Players by Revenue
3.1.1 Global Top Thalassemia Players by Revenue (2020-2025)
3.1.2 Global Thalassemia Revenue Market Share by Players (2020-2025)
3.2 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Thalassemia Revenue
3.4 Global Thalassemia Market Concentration Ratio
3.4.1 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thalassemia Revenue in 2024
3.5 Global Key Players of Thalassemia Head office and Area Served
3.6 Global Key Players of Thalassemia, Product and Application
3.7 Global Key Players of Thalassemia, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Thalassemia Breakdown Data by Type
4.1 Global Thalassemia Historic Market Size by Type (2020-2025)
4.2 Global Thalassemia Forecasted Market Size by Type (2026-2031)
5 Thalassemia Breakdown Data by Application
5.1 Global Thalassemia Historic Market Size by Application (2020-2025)
5.2 Global Thalassemia Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Thalassemia Market Size (2020-2031)
6.2 North America Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Thalassemia Market Size by Country (2020-2025)
6.4 North America Thalassemia Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thalassemia Market Size (2020-2031)
7.2 Europe Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Thalassemia Market Size by Country (2020-2025)
7.4 Europe Thalassemia Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thalassemia Market Size (2020-2031)
8.2 Asia-Pacific Thalassemia Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Thalassemia Market Size by Region (2020-2025)
8.4 Asia-Pacific Thalassemia Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thalassemia Market Size (2020-2031)
9.2 Latin America Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Thalassemia Market Size by Country (2020-2025)
9.4 Latin America Thalassemia Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thalassemia Market Size (2020-2031)
10.2 Middle East & Africa Thalassemia Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Thalassemia Market Size by Country (2020-2025)
10.4 Middle East & Africa Thalassemia Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Details
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Thalassemia Introduction
11.1.4 Emmaus Medical Revenue in Thalassemia Business (2020-2025)
11.1.5 Emmaus Medical Recent Development
11.2 Addmedica
11.2.1 Addmedica Company Details
11.2.2 Addmedica Business Overview
11.2.3 Addmedica Thalassemia Introduction
11.2.4 Addmedica Revenue in Thalassemia Business (2020-2025)
11.2.5 Addmedica Recent Development
11.3 Gamida Cell
11.3.1 Gamida Cell Company Details
11.3.2 Gamida Cell Business Overview
11.3.3 Gamida Cell Thalassemia Introduction
11.3.4 Gamida Cell Revenue in Thalassemia Business (2020-2025)
11.3.5 Gamida Cell Recent Development
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Details
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Thalassemia Introduction
11.4.4 GlycoMimetics Revenue in Thalassemia Business (2020-2025)
11.4.5 GlycoMimetics Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Thalassemia Introduction
11.5.4 Pfizer Revenue in Thalassemia Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Thalassemia Introduction
11.6.4 Novartis Revenue in Thalassemia Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Details
11.7.2 Global Blood Therapeutics Business Overview
11.7.3 Global Blood Therapeutics Thalassemia Introduction
11.7.4 Global Blood Therapeutics Revenue in Thalassemia Business (2020-2025)
11.7.5 Global Blood Therapeutics Recent Development
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Details
11.8.2 Micelle BioPharma Business Overview
11.8.3 Micelle BioPharma Thalassemia Introduction
11.8.4 Micelle BioPharma Revenue in Thalassemia Business (2020-2025)
11.8.5 Micelle BioPharma Recent Development
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Details
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio Thalassemia Introduction
11.9.4 Bluebird Bio Revenue in Thalassemia Business (2020-2025)
11.9.5 Bluebird Bio Recent Development
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Details
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Thalassemia Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Thalassemia Business (2020-2025)
11.10.5 Prolong Pharmaceuticals Recent Development
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Details
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Thalassemia Introduction
11.11.4 Modus Therapeutics Revenue in Thalassemia Business (2020-2025)
11.11.5 Modus Therapeutics Recent Development
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Details
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Thalassemia Introduction
11.12.4 Sangamo Biosciences Revenue in Thalassemia Business (2020-2025)
11.12.5 Sangamo Biosciences Recent Development
11.13 Bioverativ
11.13.1 Bioverativ Company Details
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Thalassemia Introduction
11.13.4 Bioverativ Revenue in Thalassemia Business (2020-2025)
11.13.5 Bioverativ Recent Development
11.14 Imara
11.14.1 Imara Company Details
11.14.2 Imara Business Overview
11.14.3 Imara Thalassemia Introduction
11.14.4 Imara Revenue in Thalassemia Business (2020-2025)
11.14.5 Imara Recent Development
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Thalassemia Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Thalassemia Business (2020-2025)
11.15.5 Ironwood Pharmaceuticals Recent Development
11.16 Merck (Acceleron Pharma)
11.16.1 Merck (Acceleron Pharma) Company Details
11.16.2 Merck (Acceleron Pharma) Business Overview
11.16.3 Merck (Acceleron Pharma) Thalassemia Introduction
11.16.4 Merck (Acceleron Pharma) Revenue in Thalassemia Business (2020-2025)
11.16.5 Merck (Acceleron Pharma) Recent Development
11.17 Celgene Corporation
11.17.1 Celgene Corporation Company Details
11.17.2 Celgene Corporation Business Overview
11.17.3 Celgene Corporation Thalassemia Introduction
11.17.4 Celgene Corporation Revenue in Thalassemia Business (2020-2025)
11.17.5 Celgene Corporation Recent Development
11.18 Kiadis Pharma
11.18.1 Kiadis Pharma Company Details
11.18.2 Kiadis Pharma Business Overview
11.18.3 Kiadis Pharma Thalassemia Introduction
11.18.4 Kiadis Pharma Revenue in Thalassemia Business (2020-2025)
11.18.5 Kiadis Pharma Recent Development
11.19 Incyte Corporation
11.19.1 Incyte Corporation Company Details
11.19.2 Incyte Corporation Business Overview
11.19.3 Incyte Corporation Thalassemia Introduction
11.19.4 Incyte Corporation Revenue in Thalassemia Business (2020-2025)
11.19.5 Incyte Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Thalassemia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Iron Chelation Therapy
Table 3. Key Players of Transfusion Therapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Key Players of Others
Table 6. Global Thalassemia Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Thalassemia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Thalassemia Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Thalassemia Market Share by Region (2020-2025)
Table 10. Global Thalassemia Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Thalassemia Market Share by Region (2026-2031)
Table 12. Thalassemia Market Trends
Table 13. Thalassemia Market Drivers
Table 14. Thalassemia Market Challenges
Table 15. Thalassemia Market Restraints
Table 16. Global Thalassemia Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Thalassemia Market Share by Players (2020-2025)
Table 18. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2024)
Table 19. Ranking of Global Top Thalassemia Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Thalassemia Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Thalassemia, Headquarters and Area Served
Table 22. Global Key Players of Thalassemia, Product and Application
Table 23. Global Key Players of Thalassemia, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Thalassemia Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Thalassemia Revenue Market Share by Type (2020-2025)
Table 27. Global Thalassemia Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Thalassemia Revenue Market Share by Type (2026-2031)
Table 29. Global Thalassemia Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Thalassemia Revenue Market Share by Application (2020-2025)
Table 31. Global Thalassemia Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Thalassemia Revenue Market Share by Application (2026-2031)
Table 33. North America Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Thalassemia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Thalassemia Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Thalassemia Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 48. Emmaus Medical Company Details
Table 49. Emmaus Medical Business Overview
Table 50. Emmaus Medical Thalassemia Product
Table 51. Emmaus Medical Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 52. Emmaus Medical Recent Development
Table 53. Addmedica Company Details
Table 54. Addmedica Business Overview
Table 55. Addmedica Thalassemia Product
Table 56. Addmedica Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 57. Addmedica Recent Development
Table 58. Gamida Cell Company Details
Table 59. Gamida Cell Business Overview
Table 60. Gamida Cell Thalassemia Product
Table 61. Gamida Cell Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 62. Gamida Cell Recent Development
Table 63. GlycoMimetics Company Details
Table 64. GlycoMimetics Business Overview
Table 65. GlycoMimetics Thalassemia Product
Table 66. GlycoMimetics Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 67. GlycoMimetics Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Thalassemia Product
Table 71. Pfizer Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Thalassemia Product
Table 76. Novartis Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Global Blood Therapeutics Company Details
Table 79. Global Blood Therapeutics Business Overview
Table 80. Global Blood Therapeutics Thalassemia Product
Table 81. Global Blood Therapeutics Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 82. Global Blood Therapeutics Recent Development
Table 83. Micelle BioPharma Company Details
Table 84. Micelle BioPharma Business Overview
Table 85. Micelle BioPharma Thalassemia Product
Table 86. Micelle BioPharma Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 87. Micelle BioPharma Recent Development
Table 88. Bluebird Bio Company Details
Table 89. Bluebird Bio Business Overview
Table 90. Bluebird Bio Thalassemia Product
Table 91. Bluebird Bio Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 92. Bluebird Bio Recent Development
Table 93. Prolong Pharmaceuticals Company Details
Table 94. Prolong Pharmaceuticals Business Overview
Table 95. Prolong Pharmaceuticals Thalassemia Product
Table 96. Prolong Pharmaceuticals Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 97. Prolong Pharmaceuticals Recent Development
Table 98. Modus Therapeutics Company Details
Table 99. Modus Therapeutics Business Overview
Table 100. Modus Therapeutics Thalassemia Product
Table 101. Modus Therapeutics Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 102. Modus Therapeutics Recent Development
Table 103. Sangamo Biosciences Company Details
Table 104. Sangamo Biosciences Business Overview
Table 105. Sangamo Biosciences Thalassemia Product
Table 106. Sangamo Biosciences Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 107. Sangamo Biosciences Recent Development
Table 108. Bioverativ Company Details
Table 109. Bioverativ Business Overview
Table 110. Bioverativ Thalassemia Product
Table 111. Bioverativ Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 112. Bioverativ Recent Development
Table 113. Imara Company Details
Table 114. Imara Business Overview
Table 115. Imara Thalassemia Product
Table 116. Imara Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 117. Imara Recent Development
Table 118. Ironwood Pharmaceuticals Company Details
Table 119. Ironwood Pharmaceuticals Business Overview
Table 120. Ironwood Pharmaceuticals Thalassemia Product
Table 121. Ironwood Pharmaceuticals Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 122. Ironwood Pharmaceuticals Recent Development
Table 123. Merck (Acceleron Pharma) Company Details
Table 124. Merck (Acceleron Pharma) Business Overview
Table 125. Merck (Acceleron Pharma) Thalassemia Product
Table 126. Merck (Acceleron Pharma) Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 127. Merck (Acceleron Pharma) Recent Development
Table 128. Celgene Corporation Company Details
Table 129. Celgene Corporation Business Overview
Table 130. Celgene Corporation Thalassemia Product
Table 131. Celgene Corporation Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 132. Celgene Corporation Recent Development
Table 133. Kiadis Pharma Company Details
Table 134. Kiadis Pharma Business Overview
Table 135. Kiadis Pharma Thalassemia Product
Table 136. Kiadis Pharma Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 137. Kiadis Pharma Recent Development
Table 138. Incyte Corporation Company Details
Table 139. Incyte Corporation Business Overview
Table 140. Incyte Corporation Thalassemia Product
Table 141. Incyte Corporation Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 142. Incyte Corporation Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Thalassemia Picture
Figure 2. Global Thalassemia Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Thalassemia Market Share by Type: 2024 VS 2031
Figure 4. Iron Chelation Therapy Features
Figure 5. Transfusion Therapy Features
Figure 6. Bone Marrow Transplant Features
Figure 7. Others Features
Figure 8. Global Thalassemia Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Thalassemia Market Share by Application: 2024 VS 2031
Figure 10. Aldult Case Studies
Figure 11. Newborns and Children Case Studies
Figure 12. Thalassemia Report Years Considered
Figure 13. Global Thalassemia Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Thalassemia Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Thalassemia Market Share by Region: 2024 VS 2031
Figure 16. Global Thalassemia Market Share by Players in 2024
Figure 17. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Thalassemia Revenue in 2024
Figure 19. North America Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Thalassemia Market Share by Country (2020-2031)
Figure 21. United States Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Thalassemia Market Share by Country (2020-2031)
Figure 25. Germany Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Thalassemia Market Share by Region (2020-2031)
Figure 33. China Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Thalassemia Market Share by Country (2020-2031)
Figure 41. Mexico Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Thalassemia Market Share by Country (2020-2031)
Figure 45. Turkey Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Emmaus Medical Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 49. Addmedica Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 50. Gamida Cell Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 51. GlycoMimetics Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 54. Global Blood Therapeutics Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 55. Micelle BioPharma Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 56. Bluebird Bio Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 57. Prolong Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 58. Modus Therapeutics Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 59. Sangamo Biosciences Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 60. Bioverativ Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 61. Imara Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 62. Ironwood Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 63. Merck (Acceleron Pharma) Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 64. Celgene Corporation Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 65. Kiadis Pharma Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 66. Incyte Corporation Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Thalassemia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Iron Chelation Therapy
Table 3. Key Players of Transfusion Therapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Key Players of Others
Table 6. Global Thalassemia Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Thalassemia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Thalassemia Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Thalassemia Market Share by Region (2020-2025)
Table 10. Global Thalassemia Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Thalassemia Market Share by Region (2026-2031)
Table 12. Thalassemia Market Trends
Table 13. Thalassemia Market Drivers
Table 14. Thalassemia Market Challenges
Table 15. Thalassemia Market Restraints
Table 16. Global Thalassemia Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Thalassemia Market Share by Players (2020-2025)
Table 18. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2024)
Table 19. Ranking of Global Top Thalassemia Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Thalassemia Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Thalassemia, Headquarters and Area Served
Table 22. Global Key Players of Thalassemia, Product and Application
Table 23. Global Key Players of Thalassemia, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Thalassemia Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Thalassemia Revenue Market Share by Type (2020-2025)
Table 27. Global Thalassemia Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Thalassemia Revenue Market Share by Type (2026-2031)
Table 29. Global Thalassemia Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Thalassemia Revenue Market Share by Application (2020-2025)
Table 31. Global Thalassemia Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Thalassemia Revenue Market Share by Application (2026-2031)
Table 33. North America Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Thalassemia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Thalassemia Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Thalassemia Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Thalassemia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Thalassemia Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Thalassemia Market Size by Country (2026-2031) & (US$ Million)
Table 48. Emmaus Medical Company Details
Table 49. Emmaus Medical Business Overview
Table 50. Emmaus Medical Thalassemia Product
Table 51. Emmaus Medical Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 52. Emmaus Medical Recent Development
Table 53. Addmedica Company Details
Table 54. Addmedica Business Overview
Table 55. Addmedica Thalassemia Product
Table 56. Addmedica Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 57. Addmedica Recent Development
Table 58. Gamida Cell Company Details
Table 59. Gamida Cell Business Overview
Table 60. Gamida Cell Thalassemia Product
Table 61. Gamida Cell Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 62. Gamida Cell Recent Development
Table 63. GlycoMimetics Company Details
Table 64. GlycoMimetics Business Overview
Table 65. GlycoMimetics Thalassemia Product
Table 66. GlycoMimetics Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 67. GlycoMimetics Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Thalassemia Product
Table 71. Pfizer Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Thalassemia Product
Table 76. Novartis Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Global Blood Therapeutics Company Details
Table 79. Global Blood Therapeutics Business Overview
Table 80. Global Blood Therapeutics Thalassemia Product
Table 81. Global Blood Therapeutics Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 82. Global Blood Therapeutics Recent Development
Table 83. Micelle BioPharma Company Details
Table 84. Micelle BioPharma Business Overview
Table 85. Micelle BioPharma Thalassemia Product
Table 86. Micelle BioPharma Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 87. Micelle BioPharma Recent Development
Table 88. Bluebird Bio Company Details
Table 89. Bluebird Bio Business Overview
Table 90. Bluebird Bio Thalassemia Product
Table 91. Bluebird Bio Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 92. Bluebird Bio Recent Development
Table 93. Prolong Pharmaceuticals Company Details
Table 94. Prolong Pharmaceuticals Business Overview
Table 95. Prolong Pharmaceuticals Thalassemia Product
Table 96. Prolong Pharmaceuticals Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 97. Prolong Pharmaceuticals Recent Development
Table 98. Modus Therapeutics Company Details
Table 99. Modus Therapeutics Business Overview
Table 100. Modus Therapeutics Thalassemia Product
Table 101. Modus Therapeutics Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 102. Modus Therapeutics Recent Development
Table 103. Sangamo Biosciences Company Details
Table 104. Sangamo Biosciences Business Overview
Table 105. Sangamo Biosciences Thalassemia Product
Table 106. Sangamo Biosciences Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 107. Sangamo Biosciences Recent Development
Table 108. Bioverativ Company Details
Table 109. Bioverativ Business Overview
Table 110. Bioverativ Thalassemia Product
Table 111. Bioverativ Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 112. Bioverativ Recent Development
Table 113. Imara Company Details
Table 114. Imara Business Overview
Table 115. Imara Thalassemia Product
Table 116. Imara Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 117. Imara Recent Development
Table 118. Ironwood Pharmaceuticals Company Details
Table 119. Ironwood Pharmaceuticals Business Overview
Table 120. Ironwood Pharmaceuticals Thalassemia Product
Table 121. Ironwood Pharmaceuticals Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 122. Ironwood Pharmaceuticals Recent Development
Table 123. Merck (Acceleron Pharma) Company Details
Table 124. Merck (Acceleron Pharma) Business Overview
Table 125. Merck (Acceleron Pharma) Thalassemia Product
Table 126. Merck (Acceleron Pharma) Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 127. Merck (Acceleron Pharma) Recent Development
Table 128. Celgene Corporation Company Details
Table 129. Celgene Corporation Business Overview
Table 130. Celgene Corporation Thalassemia Product
Table 131. Celgene Corporation Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 132. Celgene Corporation Recent Development
Table 133. Kiadis Pharma Company Details
Table 134. Kiadis Pharma Business Overview
Table 135. Kiadis Pharma Thalassemia Product
Table 136. Kiadis Pharma Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 137. Kiadis Pharma Recent Development
Table 138. Incyte Corporation Company Details
Table 139. Incyte Corporation Business Overview
Table 140. Incyte Corporation Thalassemia Product
Table 141. Incyte Corporation Revenue in Thalassemia Business (2020-2025) & (US$ Million)
Table 142. Incyte Corporation Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Thalassemia Picture
Figure 2. Global Thalassemia Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Thalassemia Market Share by Type: 2024 VS 2031
Figure 4. Iron Chelation Therapy Features
Figure 5. Transfusion Therapy Features
Figure 6. Bone Marrow Transplant Features
Figure 7. Others Features
Figure 8. Global Thalassemia Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Thalassemia Market Share by Application: 2024 VS 2031
Figure 10. Aldult Case Studies
Figure 11. Newborns and Children Case Studies
Figure 12. Thalassemia Report Years Considered
Figure 13. Global Thalassemia Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Thalassemia Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Thalassemia Market Share by Region: 2024 VS 2031
Figure 16. Global Thalassemia Market Share by Players in 2024
Figure 17. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Thalassemia Revenue in 2024
Figure 19. North America Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Thalassemia Market Share by Country (2020-2031)
Figure 21. United States Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Thalassemia Market Share by Country (2020-2031)
Figure 25. Germany Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Thalassemia Market Share by Region (2020-2031)
Figure 33. China Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Thalassemia Market Share by Country (2020-2031)
Figure 41. Mexico Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Thalassemia Market Share by Country (2020-2031)
Figure 45. Turkey Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Thalassemia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Emmaus Medical Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 49. Addmedica Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 50. Gamida Cell Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 51. GlycoMimetics Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 54. Global Blood Therapeutics Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 55. Micelle BioPharma Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 56. Bluebird Bio Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 57. Prolong Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 58. Modus Therapeutics Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 59. Sangamo Biosciences Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 60. Bioverativ Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 61. Imara Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 62. Ironwood Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 63. Merck (Acceleron Pharma) Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 64. Celgene Corporation Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 65. Kiadis Pharma Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 66. Incyte Corporation Revenue Growth Rate in Thalassemia Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232